Susquehanna International Group’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-118,025
| Closed | -$261K | – | 13358 |
|
|
2023
Q2 | $261K | Buy |
118,025
+42,384
| +56% | +$87.9K | ﹤0.01% | 9725 |
|
|
2023
Q1 | $192K | Buy |
75,641
+29,834
| +65% | +$59K | ﹤0.01% | 10647 |
|
|
2022
Q4 | $85.7K | Sell |
45,807
-13,552
| -23% | -$33.8K | ﹤0.01% | 11081 |
|
|
2022
Q3 | $153K | Sell |
59,359
-83,025
| -58% | -$207K | ﹤0.01% | 11215 |
|
|
2022
Q2 | $275K | Buy |
142,384
+91,846
| +182% | +$200K | ﹤0.01% | 9807 |
|
|
2022
Q1 | $150K | Sell |
50,538
-129,342
| -72% | -$487K | ﹤0.01% | 11564 |
|
|
2021
Q4 | $808K | Buy |
179,880
+15,812
| +10% | +$75K | ﹤0.01% | 7856 |
|
|
2021
Q3 | $797K | Buy |
164,068
+31,326
| +24% | +$173K | ﹤0.01% | 8143 |
|
|
2021
Q2 | $905K | Buy |
132,742
+80,646
| +155% | +$652K | ﹤0.01% | 8045 |
|
|
2021
Q1 | $368K | Buy |
52,096
+39,752
| +322% | +$286K | ﹤0.01% | 10174 |
|
|
2020
Q4 | $77K | Sell |
12,344
-64,678
| -84% | -$381K | ﹤0.01% | 10614 |
|
|
2020
Q3 | $417K | Buy |
77,022
+64,863
| +533% | +$321K | ﹤0.01% | 8055 |
|
|
2020
Q2 | $63K | Sell |
12,159
-36,149
| -75% | -$161K | ﹤0.01% | 9687 |
|
|
2020
Q1 | $152K | Sell |
48,308
-115,321
| -70% | -$425K | ﹤0.01% | 8984 |
|
|
2019
Q4 | $659K | Buy |
163,629
+54,015
| +49% | +$187K | ﹤0.01% | 6391 |
|
|
2019
Q3 | $474K | Buy |
109,614
+77,554
| +242% | +$310K | ﹤0.01% | 7421 |
|
|
2019
Q2 | $128K | Buy |
+32,060
| New | +$152K | ﹤0.01% | 9484 |
|
|
2019
Q1 | – | Sell |
-25,249
| Closed | -$163K | – | 10109 |
|
|
2018
Q4 | $130K | Sell |
25,249
-138,261
| -85% | -$1.05M | ﹤0.01% | 8078 |
|
|
2018
Q3 | $1.59M | Buy |
163,510
+107,904
| +194% | +$1.09M | ﹤0.01% | 4379 |
|
|
2018
Q2 | $567K | Sell |
55,606
-5,259
| -9% | -$59.5K | ﹤0.01% | 6540 |
|
|
2018
Q1 | $791K | Sell |
60,865
-64,230
| -51% | -$956K | ﹤0.01% | 5719 |
|
|
2017
Q4 | $2.24M | Buy |
125,095
+96,086
| +331% | +$2M | ﹤0.01% | 3708 |
|
|
2017
Q3 | $728K | Buy |
+29,009
| New | +$675K | ﹤0.01% | 5860 |
|
|
2017
Q1 | – | Sell |
-47,237
| Closed | -$744K | – | 10242 |
|
|
2016
Q4 | $727K | Buy |
+47,237
| New | +$613K | ﹤0.01% | 6192 |
|
|
2015
Q2 | – | Sell |
-11,244
| Closed | -$351K | – | 10564 |
|
|
2015
Q1 | $351K | Buy |
11,244
+5,924
| +111% | +$170K | ﹤0.01% | 7701 |
|
|
2014
Q4 | $205K | Buy |
5,320
+1,637
| +44% | +$39.1K | ﹤0.01% | 8783 |
|
|
2014
Q3 | $89K | Sell |
3,683
-8,528
| -70% | -$223K | ﹤0.01% | 9111 |
|
|
2014
Q2 | $292K | Sell |
12,211
-1,086
| -8% | -$35.4K | ﹤0.01% | 8425 |
|
|
2014
Q1 | $491K | Sell |
13,297
-30
| -0.2% | -$1.19K | ﹤0.01% | 6766 |
|
|
2013
Q4 | $537K | Buy |
13,327
+7,785
| +140% | +$331K | ﹤0.01% | 6575 |
|
|
2013
Q3 | $211K | Buy |
5,542
+411
| +8% | +$14.7K | ﹤0.01% | 7704 |
|
|
2013
Q2 | $186K | Buy |
+5,131
| New | +$220K | ﹤0.01% | 7490 |
|
Susquehanna International Group's PRTK Position: Q3 2023 in Review
Susquehanna International Group sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 118,025 shares — an estimated $261K sold.
Susquehanna International Group first reported a position in PRTK in Q2 2013 and held it in 32 quarters. The position peaked at $2.24M in Q4 2017. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- Susquehanna International Group reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 118,025 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $261K.
- Susquehanna International Group first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2013 and held it in 32 quarters.
- Susquehanna International Group's Paratek Pharmaceuticals, Inc. position peaked at $2.24M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.